Lansforsakringar Fondforvaltning Ab (Publ) Royalty Pharma PLC Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $15.9 Billion
- Q1 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 150,558 shares of RPRX stock, worth $5.25 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
150,558
Previous 150,344
0.14%
Holding current value
$5.25 Million
Previous $3.84 Million
22.19%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.43 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$802 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$467 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$424 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...